Verbeeck R K, Corman C L, Wallace S M, Herman R J, Ross S G, Le Morvan P
College of Pharmacy, University of Saskatchewan, Saskatoon, Canada.
Eur J Clin Pharmacol. 1988;35(5):521-7. doi: 10.1007/BF00558248.
The effect of cimetidine on the single and multiple dose pharmacokinetics of enteric coated ketoprofen was studied in 12 healthy volunteers. Each subject completed two 8-day study treatment periods: either ketoprofen alone (100 mg p.o. twice daily), or co-administered with cimetidine (600 mg twice daily). tlag, Cmax, tmax, t1/2, and k for ketoprofen were not significantly different between single and multiple dose administration. AUC of ketoprofen was slightly but significantly larger following multiple (21.2 micrograms.h.ml-1) as compared to single dose administration (19.0 micrograms.h.ml-1). As a result, plasma clearance of ketoprofen was slightly but significantly reduced following multiple dose administration (80.6 ml/min vs 89.3 ml/min). Cimetidine had no effect on the single or multiple dose pharmacokinetics of enteric coated ketoprofen. Total 12-h urinary recovery of ketoprofen (mostly in the form of ketoprofen glucuronide) was 83.5% of the dose following single dose administration and was significantly greater following multiple dose administration (93.1%). Again cimetidine co-administration had no effect on the single and multiple dose urinary recovery. The results of this study show that cimetidine is not affecting the oral pharmacokinetics of enteric coated ketoprofen.
在12名健康志愿者中研究了西咪替丁对肠溶包衣酮洛芬单剂量和多剂量药代动力学的影响。每位受试者完成两个为期8天的研究治疗期:单独服用酮洛芬(口服100 mg,每日两次),或与西咪替丁联合服用(每日两次,600 mg)。酮洛芬的滞后时间、Cmax、tmax、t1/2和k在单剂量和多剂量给药之间无显著差异。与单剂量给药(19.0微克·小时·毫升-1)相比,酮洛芬的多剂量给药后的AUC略有增加但显著增大(21.2微克·小时·毫升-1)。结果,多剂量给药后酮洛芬的血浆清除率略有降低但显著降低(80.6毫升/分钟对89.3毫升/分钟)。西咪替丁对肠溶包衣酮洛芬的单剂量或多剂量药代动力学无影响。单剂量给药后,酮洛芬12小时尿总回收率(主要以酮洛芬葡萄糖醛酸苷形式)为给药剂量的83.5%,多剂量给药后显著更高(93.1%)。同样,联合使用西咪替丁对单剂量和多剂量尿回收率无影响。本研究结果表明,西咪替丁不影响肠溶包衣酮洛芬的口服药代动力学。